The pharmaceutical firm has confronted challenges with degradation of the 2 lively parts of cagrisema, cagrilintide and semaglutide, when dissolved in syringes.
发布者:BY CHRISTIAN BUNDGAARD,转转请注明出处:https://robotalks.cn/novo-nordisk-initiates-study-with-updated-version-of-cagrisema/